No Data
No Data
XOMA CORP DEPOSITARY SH REPR 1/1000TH B CUM PERP P To Go Ex-Dividend On July 3rd, 2024 With 0.52344 USD Dividend Per Share
XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals' Sale of Its Priority Review Voucher
XOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQ
10-Q: Quarterly report
XOMA Reports First Quarter 2024 Financial Results and Highlights Recent Activities
XOMA Adds Economic Interests in Three First-in-Category Assets to Its Royalty and Milestone Portfolio Including XACIATO (Clindamycin Phosphate) Vaginal Gel 2%
No Data